CAUSEY CHRISTOPHER
SEC Form 4 insider trading activity
CAUSEY CHRISTOPHER has filed 9 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Mar 31, 2026.
On the most recent filing, CAUSEY CHRISTOPHER is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, CAUSEY CHRISTOPHER reported no open-market purchases and 5 open-market sales totaling $2.3M in UTHR. The largest disclosed transaction in the window is a sale of 1,300 UTHR shares on Mar 30, 2026, worth $786K.
Companies traded
Other insiders at UTHR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 24, 2025 | UTHR | Sale | $440K |
| Sep 2, 2025 | UTHR | Sale | $420K |
| Sep 2, 2025 | UTHR | Sale | $430K |
| Sep 2, 2025 | UTHR | Sale | $420K |
Frequently asked questions
How many SEC Form 4 filings has CAUSEY CHRISTOPHER made?
CAUSEY CHRISTOPHER has filed 9 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.
Which companies does CAUSEY CHRISTOPHER trade?
CAUSEY CHRISTOPHER has filed SEC Form 4 disclosures for 1 company, including UTHR.
When was CAUSEY CHRISTOPHER's most recent SEC Form 4 filing?
CAUSEY CHRISTOPHER's most recent SEC Form 4 filing on Tracefour is dated Mar 31, 2026.
What is CAUSEY CHRISTOPHER's total buy and sell value in the current window?
Inside the rolling retention window, CAUSEY CHRISTOPHER bought $0 and sold $2.3M based on SEC Form 4 filings.
What was CAUSEY CHRISTOPHER's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,300 UTHR shares on 2026-03-30, worth $786K, per SEC Form 4 filings.